Analysis of the effectiveness of the combination of bevacizumab and irinotecan for the treatment of glial tumors. RSD [Internet]. 2022 Jan. 9 [cited 2025 Dec. 15];11(1):e37911125135. Available from: https://www.rsdjournal.org/rsd/article/view/25135